UT Southwestern physician-scientists will share research and clinical advances at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO). Check out our schedule below we would love to see you at any or all of our sessions.
Featured Speakers:
Session Name: Oligometastatic Renal Cell Carcinoma: Observe, Excise, Ablate?
Date: 6-Jun-23
Time: 10:15-10:30AM
Speaker: Raquibul Hannan, MD, PhD
Presentation Title: When Is Stereotactic Ablative Body Radiotherapy an Option?
Track: Genitourinary Cancer—Kidney and Bladder
Link: More Information
Session Name:Minimizing Toxicity in the Neoadjuvant Treatment for Rectal Cancer
Date: 4-Jun-23
Time: 11:45AM-12:00PM
Speaker: Nina Niu Sanford, MD
Presentation Title: Evolving Role of Radiation in Rectal Cancer: Optimizing a Crucial Tool
Track: Gastrointestinal Cancer—Colorectal and Anal
Link: More Information
Posters:
Track: Developmental Therapeutics—Immunotherapy
Date: 3-Jun-23
Time: 8:00 AM
Author: Vishnu Venkatesh, MD
Title: Prospective cardiovascular surveillance of immune checkpoint inhibitor-based combination therapy in patients with early-stage, triple-negative breast cancer.
Link: More Information
Track: Breast Cancer - Local/Regional/Adjuvant
Date: 4-Jun-23
Time: 8:00 AM
Author: Heather L. McArthur, MD, MPH
Title: Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial.
Link: More Information
Track: Breast Cancer - Local/Regional/Adjuvant
Date: 4-Jun-23
Time: 8:00 AM
Author: Heather L. McArthur, MD, MPH
Title: A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.
Link: More Information
Track: Health Services Research and Quality Improvement
Date: 3-Jun-23
Time: 1:15 PM
Author: Amy Little Jones, MD
Title: Reducing infusion center wait times in a resource-limited setting.
Link: More Information
Track: Care Delivery and Regulatory Policy
Date: 5-Jun-23
Time: 1:15 PM
Author: Arthur Hong, MD, MPH
Title: English- and Spanish-preferring patient perspectives on managing acute care needs at two disparate health systems.
Link: More Information
Track: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Date: 5-Jun-23
Time: 8:00 AM
Author: Mir Lim, MD
Title: Individual patient-level data validation of surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma: Post-hoc analysis of IMbrave150 and real-world observations.
Link: More Information
Track: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Date: 5-Jun-23
Time: 8:00 AM
Author: Naveen Premnath, MD
Title: Shattering myths regarding Hispanic ethnicity and survival in acute myeloid leukemia: Insights from the National Cancer Database.
Link: More Information
Track: Prevention, Risk Reduction, and Hereditary Cancer
Date: 3-Jun-23
Time: 1:15 PM
Author: Sheena Bhalla, MD
Title: Patient navigation for lung cancer screening in an urban safety-net system: A pragmatic randomized clinical trial.
Link: More Information
Track: Symptoms and Survivorship
Date: 5-Jun-23
Time: 8:00 AM
Author: Naveen Premnath, MD
Title: Patient navigation for lung cancer screening in an urban safety-net system: A pragmatic randomized clinical trial.
Link: More Information
Track: Genitourinary Cancer—Prostate, Testicular, and Penile
Date: 3-Jun-23
Time: 8:00 AM
Author: Tian Zhang, MD, MHS
Title: Primary analysis of STARTAR: A phase 2 salvage trial of androgen receptor (AR) inhibition with androgen deprivation therapy (ADT) and apalutamide with radiation therapy (RT) followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).
Link: More Information